SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ronghui Xu, Yunjun Luo, Robert Glynn, Diana Johnson, Kenneth Jones, Christina Chambers, Time-Dependent Propensity Score for Assessing the Effect of Vaccine Exposure on Pregnancy Outcomes through Pregnancy Exposure Cohort Studies, International Journal of Environmental Research and Public Health, 2014, 11, 3, 3074

    CrossRef

  2. 2
    Christina D. Chambers, Diana Johnson, Ronghui Xu, Yunjun Luo, Carol Louik, Allen A. Mitchell, Michael Schatz, Kenneth L. Jones, Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, Vaccine, 2013, 31, 44, 5026

    CrossRef

  3. 3
    Dee Quinn, Funding for teratology information services: Up, down, and all around, Birth Defects Research Part A: Clinical and Molecular Teratology, 2012, 94, 8
  4. 4
    M. Cassina, D. L. Johnson, L. K. Robinson, S. R. Braddock, R. Xu, J. L. Jimenez, N. Mirrasoul, E. Salas, Y. J. Luo, K. L. Jones, C. D. Chambers, Pregnancy outcome in women exposed to leflunomide before or during pregnancy, Arthritis & Rheumatism, 2012, 64, 7
  5. 5
    Haruna Sawada Feldman, Kenneth Lyons Jones, Suzanne Lindsay, Donald Slymen, Hillary Klonoff-Cohen, Kelly Kao, Smriti Rao, Christina Chambers, Prenatal Alcohol Exposure Patterns and Alcohol-Related Birth Defects and Growth Deficiencies: A Prospective Study, Alcoholism: Clinical and Experimental Research, 2012, 36, 4
  6. 6
    Jane Adams, Patricia A. Janulewicz, Kelly Kao, Kenneth Lyons Jones, Christina Chambers, The CTIS Womb to Classroom Screening Program for the detection of agents with adverse effects on neuropsychological development, Birth Defects Research Part A: Clinical and Molecular Teratology, 2012, 94, 6
  7. 7
    Ronghui Xu, Christina Chambers, A sample size calculation for spontaneous abortion in observational studies, Reproductive Toxicology, 2011, 32, 4, 490

    CrossRef

  8. 8
    Haruna Sawada Feldman, Kenneth Lyons Jones, Suzanne Lindsay, Donald Slymen, Hillary Klonoff-Cohen, Kelly Kao, Smriti Rao, Christina Chambers, Patterns of prenatal alcohol exposure and associated non-characteristic minor structural malformations: A prospective study, American Journal of Medical Genetics Part A, 2011, 155, 12
  9. 9
    Kenneth Lyons Jones, John C. Carey, The importance of dysmorphology in the identification of new human teratogens, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011, 157, 3
  10. 10
    Christina Chambers, The role of teratology information services in screening for teratogenic exposures: Challenges and opportunities, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011, 157, 3
  11. You have free access to this content11
    Christina D. Chambers, Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens, Congenital Anomalies, 2011, 51, 1
  12. 12
    Catalin S. Buhimschi, Carl P. Weiner, High Risk Pregnancy, 2011,

    CrossRef

  13. 13
    Christina D. Chambers, Diana L. Johnson, Luther K. Robinson, Stephen R. Braddock, Ronghui Xu, Janina Lopez-Jimenez, Nicole Mirrasoul, Elizabeth Salas, Yunjun J. Luo, Shelia Jin, Kenneth Lyons Jones, Birth outcomes in women who have taken leflunomide during pregnancy, Arthritis & Rheumatism, 2010, 62, 5
  14. 14
    Keele E. Wurst, Charles Poole, Sara A. Ephross, Andrew F. Olshan, First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: A meta-analysis of epidemiological studies, Birth Defects Research Part A: Clinical and Molecular Teratology, 2010, 88, 3
  15. 15
    Judith H. Miles, T. Nicole Takahashi, Julie Hong, Nicole Munden, Nancy Flournoy, Stephen R. Braddock, Rick A. Martin, M. Anne Spence, Richard E. Hillman, Janet E. Farmer, Development and validation of a measure of dysmorphology: Useful for autism subgroup classification, American Journal of Medical Genetics Part A, 2008, 146A, 9
  16. 16
    J. Bloch, C. Cans, C. de Vigan, L. de Brosses, B. Doray, B. Larroque, I. Perthus, Faisabilité de la surveillance du syndrome d’alcoolisation fœtale (SAF), Archives de Pédiatrie, 2008, 15, 5, 507

    CrossRef

  17. 17
    Adrienne Einarson, Donna Lockett, Do we have a knowledge transfer and translation plan at Teratogen Information Services?, Reproductive Toxicology, 2006, 22, 3, 542

    CrossRef

  18. 18
    Dianne B. McKay, Michelle A. Josephson, Pregnancy in Recipients of Solid Organs — Effects on Mother and Child, New England Journal of Medicine, 2006, 354, 12, 1281

    CrossRef

  19. 19
    Jane Adams, Patricia Janulewicz, Jennifer Anne Lantz Gavin, Human Developmental Neurotoxicology, 2006,

    CrossRef

  20. 20
    Dianne L Kennedy, Kathleen Uhl, Sandra L Kweder, Pregnancy Exposure Registries, Drug Safety, 2004, 27, 4, 215

    CrossRef

  21. 21
    Gerald G. Briggs, Roger K. Freeman, Sumner J. Yaffe, Classification of drugs for teratogenic risk: An anachronistic way of counseling: A reply to Merlob and Stahl, Birth Defects Research Part A: Clinical and Molecular Teratology, 2003, 67, 3
  22. 22
    Janine E. Polifka, J.M. Friedman, Developmental toxicity of ribavirin/IFα combination therapy: Is the label more dangerous than the drugs?, Birth Defects Research Part A: Clinical and Molecular Teratology, 2003, 67, 1
  23. 23
    Sonja A. Rasmussen, Richard S. Olney, Lewis B. Holmes, Angela E. Lin, Kim M. Keppler-Noreuil, Cynthia A. Moore, Guidelines for case classification for the national birth defects prevention study, Birth Defects Research Part A: Clinical and Molecular Teratology, 2003, 67, 3
  24. 24
    Allen A. Mitchell, Systematic Identification of Drugs That Cause Birth Defects — A New Opportunity, New England Journal of Medicine, 2003, 349, 26, 2556

    CrossRef

  25. 25
    Current Awareness, Pharmacoepidemiology and Drug Safety, 2002, 11, 3
  26. You have free access to this content26
    Current Awareness, Prenatal Diagnosis, 2002, 22, 2
  27. 27
    Janine E. Polifka, Elaine M. Faustman, Developmental toxicity: web resources for evaluating risk in humans, Toxicology, 2002, 173, 1-2, 35

    CrossRef

  28. 28
    Kenneth Lyons Jones, Diana L. Johnson, Christina D. Chambers, Monitoring leflunomide (Arava) as a new potential teratogen, Teratology, 2002, 65, 5
  29. 29
    Kenneth Lyons Jones, Kathleen A. Johnson, Lyn M. Dick, Robert J. Felix, Kelly K. Kao, Christina D. Chambers, Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine, Teratology, 2002, 65, 3
  30. 30
    Christina D. Chambers, Elizabeth B. Andrews, Drug Safety in Pregnancy,
  31. 31
    David Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Sean Hennessy, Robert L. Davis, Robert T. Chen, Roselie A. Bright, Allen A. Mitchell, David J. Graham, David W. Bates, Brian L. Strom, Special Applications of Pharmacoepidemiology,
  32. 32
    David Lee, Sumit R. Majumdar, Helene L. Lipton, Stephen B. Soumerai, Claudia Vellozzi, Robert T. Chen, Jason Glanz, Danica Marinac-Dabic, Sharon-Lise T. Normand, Art Sedrakyan, Allen A. Mitchell, Gerald J. Dal Pan, Stella Blackburn, Claudia Manzo, Hanna M. Seidling, David W. Bates, Melissa A. Robb, Rachel E. Sherman, Brian L. Strom, Rita Schinnar, Sean Hennessy, Special Applications of Pharmacoepidemiology,
  33. 33
    Allen A. Mitchell, Studies of Drug-Induced Birth Defects,